1. Home
  2. INM vs AEMD Comparison

INM vs AEMD Comparison

Compare INM & AEMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INM
  • AEMD
  • Stock Information
  • Founded
  • INM 1981
  • AEMD 1984
  • Country
  • INM Canada
  • AEMD United States
  • Employees
  • INM N/A
  • AEMD N/A
  • Industry
  • INM Biotechnology: Pharmaceutical Preparations
  • AEMD Medical/Dental Instruments
  • Sector
  • INM Health Care
  • AEMD Health Care
  • Exchange
  • INM Nasdaq
  • AEMD Nasdaq
  • Market Cap
  • INM 4.1M
  • AEMD 3.4M
  • IPO Year
  • INM N/A
  • AEMD N/A
  • Fundamental
  • Price
  • INM $1.70
  • AEMD $5.10
  • Analyst Decision
  • INM
  • AEMD Buy
  • Analyst Count
  • INM 0
  • AEMD 2
  • Target Price
  • INM N/A
  • AEMD $287.50
  • AVG Volume (30 Days)
  • INM 61.5K
  • AEMD 50.4K
  • Earning Date
  • INM 11-06-2025
  • AEMD 11-12-2025
  • Dividend Yield
  • INM N/A
  • AEMD N/A
  • EPS Growth
  • INM N/A
  • AEMD N/A
  • EPS
  • INM N/A
  • AEMD N/A
  • Revenue
  • INM $4,798,116.00
  • AEMD N/A
  • Revenue This Year
  • INM N/A
  • AEMD N/A
  • Revenue Next Year
  • INM N/A
  • AEMD N/A
  • P/E Ratio
  • INM N/A
  • AEMD N/A
  • Revenue Growth
  • INM N/A
  • AEMD N/A
  • 52 Week Low
  • INM $1.56
  • AEMD $4.02
  • 52 Week High
  • INM $8.27
  • AEMD $84.40
  • Technical
  • Relative Strength Index (RSI)
  • INM 36.70
  • AEMD 64.85
  • Support Level
  • INM $1.59
  • AEMD $4.13
  • Resistance Level
  • INM $1.91
  • AEMD $4.60
  • Average True Range (ATR)
  • INM 0.10
  • AEMD 0.39
  • MACD
  • INM 0.00
  • AEMD -0.14
  • Stochastic Oscillator
  • INM 29.47
  • AEMD 57.22

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.

About AEMD Aethlon Medical Inc.

Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.

Share on Social Networks: